Sonnet BioTherapeutics Inc (SONN)

[BooDog]

I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.

[maq1214]

Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !

[81vette]

23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this

[81vette]

They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising

[maq1214]

Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot

[81vette]

$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now

[81vette]

254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading

[81vette]

5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m

[BooDog]

Riding free again.

[Monksdream]

SONN under $2

[crowin]

Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30

[maq1214]

This should get exciting soon, crazy volume yesterday !

[BooDog]

IS it just greed or might this make good for another round trip? We'll see next week.

[BooDog]

Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report

[Monksdream]

SONN new 52 week low

[BooDog]

Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208

[valleybenedetto]

Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now

[Monksdream]

SONN new 52 week low

[Monksdream]

SONN new 52 week low

[Monksdream]

SONN new 52 week low

[Monksdream]

SONN new 52 week low

[valleybenedetto]

If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.

[Monksdream]

If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it

[valleybenedetto]

You worry about you ok?

[Monksdream]

You aren’t getting any money back
Time to move on

[valleybenedetto]

Not an Urban Myth ..I've already checked. They have current D and O insurance.

[Monksdream]

Oh goddamn tell me another urban myth

[valleybenedetto]

They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know

[Monksdream]

You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago

[valleybenedetto]

CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.

[Monksdream]

SONN new 52 week low

[Golden Cross]

Might be a short play here now

[Golden Cross]

Very true.....

[antman]

...During his testimony, Elon Musk called short selling “a means for, in my opinion, bad people on Wall Street to steal money from small investors.”

[tw0122]

Biotech CEOs are mostly Wall Street whores they get compensated to short there own companies as it’s much more lucrative. They take on that toxic financing do reverse splits as part of their regular routine. Take MULN CEO for example he has no scruples or morals nor does he hide his screwing over shareholders.
As far as trading you play the post reverse splits at the right time with the low float and that is where the loot is made.
Wall Street casino.

[valleybenedetto]

CEO is an incompetent whore. Stock ran to 1.20 . Instead of letting it sit for 10 days and regain compliance he jammed an offering down and screwed everyone.

[antman]

I guess the shorts just crush all these companies and force them to do rollbacks

[Golden Cross]

Don't see the vote not passing now

[Golden Cross]

Nothing has gone right since the offering.. Time for a turnaround here... loading up

[Golden Cross]

Yep

[govprs]

Did you see the letter to shareholders?

[Golden Cross]

needs something here

[TimeFades]

See if she can start a new uptrend

[tw0122]

Nice to see the new Fibonacci targets going the other way now

[Golden Cross]

$SONN Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
https://www.accesswire.com/773690/Sonnet-BioTherapeutics-Provides-Fiscal-Year-2023-Third-Quarter-Business-and-Earnings-Update

[limer814]

$SONN Whoever John Markey is ,he knows something we don't. Another 13g filed this am . He is up to 4.1m shares now..I'm still holding pic.twitter.com/AW4hN0Secj

— Keith Rah (@keith_rah) August 7, 2023

[starkd748]

Around .27 gap fill....Glad I read charts prs and filings about share purchases don't mean squat

[surf1944]

https://stockcharts.com/h-sc/ui?s=sonn&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/sonn/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/sonn/opinion

[Golden Cross]

Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
https://www.accesswire.com/771212/Sonnet-BioTherapeutics-to-Present-at-the-2023-BTIG-Virtual-Biotechnology-Conference

[Golden Cross]

That didn't look good